Xiromerisiou, G.; Lampropoulos, I.C.; Dermitzakis, E.V.; Vikelis, M.; Marogianni, C.; Mysiris, D.; Argyriou, A.A.
Single OnabotulinumtoxinA Session Add-On to Carbamazepine or Oxcarbazepine in Treatment-Refractory Trigeminal Neuralgia: A Case Series with 24-Week Follow Up. Toxins 2023, 15, 539.
https://doi.org/10.3390/toxins15090539
AMA Style
Xiromerisiou G, Lampropoulos IC, Dermitzakis EV, Vikelis M, Marogianni C, Mysiris D, Argyriou AA.
Single OnabotulinumtoxinA Session Add-On to Carbamazepine or Oxcarbazepine in Treatment-Refractory Trigeminal Neuralgia: A Case Series with 24-Week Follow Up. Toxins. 2023; 15(9):539.
https://doi.org/10.3390/toxins15090539
Chicago/Turabian Style
Xiromerisiou, Georgia, Ioannis C. Lampropoulos, Emmanouil V. Dermitzakis, Michail Vikelis, Chrysoula Marogianni, Dimitrios Mysiris, and Andreas A. Argyriou.
2023. "Single OnabotulinumtoxinA Session Add-On to Carbamazepine or Oxcarbazepine in Treatment-Refractory Trigeminal Neuralgia: A Case Series with 24-Week Follow Up" Toxins 15, no. 9: 539.
https://doi.org/10.3390/toxins15090539
APA Style
Xiromerisiou, G., Lampropoulos, I. C., Dermitzakis, E. V., Vikelis, M., Marogianni, C., Mysiris, D., & Argyriou, A. A.
(2023). Single OnabotulinumtoxinA Session Add-On to Carbamazepine or Oxcarbazepine in Treatment-Refractory Trigeminal Neuralgia: A Case Series with 24-Week Follow Up. Toxins, 15(9), 539.
https://doi.org/10.3390/toxins15090539